Epigenetic mechanisms linking diabetes and synaptic impairments

Area of Science:

• Neuroscience
• Epigenetics
• Metabolic Disorders

Background:

• Diabetes is a significant risk factor for dementia, but the underlying molecular mechanisms remain unclear.
• Epigenetic modifications are implicated in diabetes pathogenesis and may influence brain function.

Purpose of the Study:

• To investigate the epigenetic changes in the brain associated with diabetes-induced dementia risk.
• To explore the role of histone deacetylases (HDACs) class IIa in diabetes-related cognitive decline.

Main Methods:

• Comparative analysis of HDAC class IIa expression in the brains of diabetic and control subjects.
• Utilized a mouse model of diet-induced type 2 diabetes (T2D) to study brain alterations.
• Assessed synaptic protein expression and susceptibility to amyloid-beta (Aβ) oligomers in T2D mice.
• Investigated the effect of pharmacological HDAC IIa inhibition on synaptic plasticity.

Main Results:

• Diabetic subjects and T2D mice exhibited elevated brain expression of HDAC class IIa compared to controls.
• Increased HDAC IIa expression correlated with altered synaptic protein levels and impaired synaptic function in T2D mice.
• T2D mice showed increased susceptibility to Aβ-induced synaptic impairments.
• Pharmacological inhibition of HDAC IIa successfully restored synaptic plasticity in T2D mice.

Conclusions:

• Diabetes induces epigenetic modifications in the brain, specifically increasing HDAC class IIa expression.
• These epigenetic changes contribute to neuropathological mechanisms, increasing susceptibility to neurodegeneration and vascular impairments.
• This study offers the first epigenetic explanation for the heightened risk of dementia in diabetic patients.